Table 1 Interaction of 28 genome-wide significant BCC associations in stage 1 with melanoma.

From: Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma

SNP

Gene

N effect

N SE

N P

Y effect

Y SE

Y P

IntP

rs12203592

IRF4

0.397

0.017

5.4 × 10−117

0.454

0.060

4.5 × 10−14

0.040

rs1805007

MC1R

0.321

0.023

8.8 × 10−41

0.272

0.077

4.7 × 10−4

0.286

rs214785

TGM3

−0.197

0.017

1.7 × 10−29

−0.044

0.065

5.0 × 10−1

0.213

rs35407

SLC45A2

0.483

0.053

1.1 × 10−22

0.537

0.239

2.0 × 10−2

0.751

rs6059655

RALY

−0.219

0.024

5.7 × 10−19

−0.141

0.082

8.5 × 10−2

0.088

rs57142672

RCC2

0.128

0.014

1.2 × 10−18

0.214

0.052

4.4 × 10−5

0.612

rs73635312

GATA3

0.189

0.021

3.5 × 10−20

0.109

0.074

1.4 × 10−1

0.047

rs1126809

TYR

−0.126

0.015

2.3 × 10−16

−0.070

0.053

1.8 × 10−1

0.521

rs421284

CLPTM1L

0.138

0.014

1.1 × 10−22

0.046

0.050

3.5 × 10−1

0.783

rs2080303

ALS2CR12/CASP8

0.122

0.016

1.1 × 10−14

0.068

0.057

2.3 × 10−1

0.425

rs61824911

RHOU

0.139

0.016

9.3 × 10−18

−0.023

0.061

7.1 × 10−1

0.300

rs2116709

FOXP1/EIF4E3

−0.116

0.015

1.3 × 10−14

−0.061

0.054

2.6 × 10−1

0.136

rs12916300

OCA2/HERC2

0.142

0.019

9.7 × 10−15

−0.024

0.067

7.2 × 10−1

0.761

rs141115006

RGS22

−0.143

0.020

3.1 × 10−13

−0.077

0.071

2.8 × 10−1

0.819

rs10810657

BNC2

−0.108

0.014

7.2 × 10−14

−0.078

0.052

1.4 × 10−1

0.986

rs10093547

ZFHX4

0.219

0.031

5.1 × 10−13

0.147

0.106

1.6 × 10−1

0.755

rs191177147

LPP

0.114

0.016

6.3 × 10−13

0.009

0.057

8.8 × 10−1

0.517

rs9275642

HLA-DQB1/DQA2

−0.123

0.019

2.4 × 10−11

−0.080

0.065

2.2 × 10−1

0.346

rs7874604

CDKN2B

0.098

0.015

1.6 × 10−10

0.095

0.055

8.5 × 10−2

0.591

rs11170164

KRT5

0.163

0.025

1.2 × 10−10

0.134

0.094

1.6 × 10−1

0.303

rs73183643

CUX1

0.109

0.017

1.1 × 10−10

0.067

0.060

2.6 × 10−1

0.391

rs11993814

ZBTB10

−0.097

0.016

2.1 × 10−9

−0.146

0.058

1.2 × 10−2

0.413

rs2776353

LINC00111

−0.092

0.015

1.5 × 10−9

−0.063

0.055

2.5 × 10−1

0.623

rs1765871

ATP11A

−0.068

0.014

1.1 × 10−6

−0.145

0.052

4.8 × 10−3

0.981

rs10425559

TICAM1/PLIN3

0.086

0.014

2.7 × 10−9

0.004

0.052

9.3 × 10−1

0.458

rs1050529

HLA-B

−0.106

0.019

2.5 × 10−8

−0.096

0.069

1.7 × 10−1

0.486

rs7776701

TNS3

−0.081

0.014

6.9 × 10−9

0.041

0.050

4.1 × 10−1

0.711

rs78097823

TTC28

0.164

0.034

2.4 × 10−6

0.354

0.120

3.5 × 10−3

0.466

  1. Results generated from logistic regression models fit separately in melanoma controls (N) and cases (Y). Includes P-value (Int P) from a likelihood ratio test for adding an interaction with melanoma status to the GWAS model. Of the 274,252 BCC controls, 3138 were melanoma cases and 268,282 were melanoma controls. Of the 12,945 BCC cases, 1,350 were melanoma cases and 11,465 were melanoma controls.